- Home
- AGIO vs TNC Comparison
AGIO vs TNC Comparison
Compare AGIO & TNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- TNC
- Stock Information
- Founded
- AGIO 2007
- TNC 1870
- Country
- AGIO United States
- TNC United States
- Employees
- AGIO N/A
- TNC N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- TNC Industrial Machinery/Components
- Sector
- AGIO Health Care
- TNC Industrials
- Exchange
- AGIO Nasdaq
- TNC Nasdaq
- Market Cap
- AGIO 1.4B
- TNC 1.4B
- IPO Year
- AGIO 2013
- TNC N/A
- Fundamental
- Price
- AGIO $35.00
- TNC $81.16
- Analyst Decision
- AGIO Buy
- TNC Strong Buy
- Analyst Count
- AGIO 6
- TNC 1
- Target Price
- AGIO $57.40
- TNC $125.00
- AVG Volume (30 Days)
- AGIO 840.6K
- TNC 110.0K
- Earning Date
- AGIO 07-31-2025
- TNC 08-06-2025
- Dividend Yield
- AGIO N/A
- TNC 1.45%
- EPS Growth
- AGIO N/A
- TNC N/A
- EPS
- AGIO 11.13
- TNC 3.58
- Revenue
- AGIO $40,875,000.00
- TNC $1,265,700,000.00
- Revenue This Year
- AGIO $18.94
- TNC N/A
- Revenue Next Year
- AGIO $201.70
- TNC $4.25
- P/E Ratio
- AGIO $3.15
- TNC $22.64
- Revenue Growth
- AGIO 30.57
- TNC 1.35
- 52 Week Low
- AGIO $23.42
- TNC $67.32
- 52 Week High
- AGIO $62.58
- TNC $108.12
- Technical
- Relative Strength Index (RSI)
- AGIO 38.99
- TNC 52.32
- Support Level
- AGIO $37.09
- TNC $80.55
- Resistance Level
- AGIO $39.12
- TNC $83.48
- Average True Range (ATR)
- AGIO 1.78
- TNC 1.76
- MACD
- AGIO -0.67
- TNC -0.21
- Stochastic Oscillator
- AGIO 9.16
- TNC 45.72
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.